25 related articles for article (PubMed ID: 2836290)
1. A monoclonal antibody to the carbohydrate chain on human hepatocellular carcinoma-associated antigen which suppressed tumor growth in nude mice.
Fukuda Y; Imai K; Miura K; Matsui M; Nakanishi T; Nakazato H; Masukawa J; Higashide T; Hinoda Y; Noguchi T
Cancer Immunol Immunother; 1988; 27(1):26-32. PubMed ID: 2840199
[TBL] [Abstract][Full Text] [Related]
2. Nuclear matrix protein 2 antibody-positive dermatomyositis associated with hepatocellular carcinoma.
Ueda Y; Shimada K
Rheumatol Adv Pract; 2023; 7(2):rkad066. PubMed ID: 37564124
[No Abstract] [Full Text] [Related]
3. Open reading frame 8a of the human severe acute respiratory syndrome coronavirus not only promotes viral replication but also induces apoptosis.
Chen CY; Ping YH; Lee HC; Chen KH; Lee YM; Chan YJ; Lien TC; Jap TS; Lin CH; Kao LS; Chen YM
J Infect Dis; 2007 Aug; 196(3):405-15. PubMed ID: 17597455
[TBL] [Abstract][Full Text] [Related]
4. Antinuclear antibodies as potential markers of lung cancer.
Fernández-Madrid F; VandeVord PJ; Yang X; Karvonen RL; Simpson PM; Kraut MJ; Granda JL; Tomkiel JE
Clin Cancer Res; 1999 Jun; 5(6):1393-400. PubMed ID: 10389924
[TBL] [Abstract][Full Text] [Related]
5. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies.
Imai H; Ochs RL; Kiyosawa K; Furuta S; Nakamura RM; Tan EM
Am J Pathol; 1992 Apr; 140(4):859-70. PubMed ID: 1314027
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies as targeting and therapeutic agents: prospects for liver transplantation, hepatitis and hepatocellular carcinoma.
Luk JM; Wong KF
Clin Exp Pharmacol Physiol; 2006; 33(5-6):482-8. PubMed ID: 16700883
[TBL] [Abstract][Full Text] [Related]
7. The spectrum of complement-fixing antinuclear antibodies in patients with hepatocellular carcinoma.
Kiyosawa K; Daemer RJ; He LF; Bonino F; Prozesky OW; Purcell RH
Hepatology; 1985; 5(4):548-55. PubMed ID: 2991105
[TBL] [Abstract][Full Text] [Related]
8. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma.
Imai H; Nakano Y; Kiyosawa K; Tan EM
Cancer; 1993 Jan; 71(1):26-35. PubMed ID: 8380118
[TBL] [Abstract][Full Text] [Related]
9. Circulating immune complexes in the sera and ascites of hepatocellular carcinoma or chronic hepatitis patients.
Chen YM; Hu CP; Wong FH; Chen PH; Tsai YT; Lee SD; Liu JD; Chang CM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):34-45. PubMed ID: 3028719
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies against antigens expressed on human hepatocellular carcinoma cells.
Hu CP; Han SH; Lui WY; Hsu HC; Lin YM; Lin PH; Chen LR; Hsieh HG; Kuo PT; P'eng FK
Hepatology; 1986; 6(6):1396-402. PubMed ID: 3025071
[TBL] [Abstract][Full Text] [Related]
11. Detection of tumour antigens in sera of patients with hepatocellular carcinoma using monoclonal antibodies.
Wong LY; Chan SH; Oon CJ
Asian Pac J Allergy Immunol; 1990 Dec; 8(2):83-6. PubMed ID: 1965408
[TBL] [Abstract][Full Text] [Related]
12. Nuclear antigens reacted with sera and ascites of hepatocellular carcinoma patients.
Chen YM; Hu CP; Chen PH; Chu MH; Tsai YT; Lee SD; Chang CM
Hepatology; 1988; 8(3):547-52. PubMed ID: 2836290
[TBL] [Abstract][Full Text] [Related]
13. Antibody-directed therapy for human hepatocellular carcinoma.
Mohr L; Yeung A; Aloman C; Wittrup D; Wands JR
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S225-31. PubMed ID: 15508088
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
